Magnetic Resonance Imaging
Volume 28, Issue 7 , Pages 936-942 , September 2010

Cine-MRI and 31P-MRS for evaluation of myocardial energy metabolism and function following coronary artery bypass graft

  • Zhuoli Zhang

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China
    • Department of Radiology, Northwestern University, Chicago, IL 60611, USA
    • With equal contribution: Zhuoli Zhang, MD, PhD; Junxia Li, MD, PhD.
    • ,
  • Junxia Li

      Affiliations

    • Department of Cardiology, Bethune International Peace Hospital, Shijiazhuang 050082, People's Republic of China
    • Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China
    • With equal contribution: Zhuoli Zhang, MD, PhD; Junxia Li, MD, PhD.
    • ,
  • Shengyong Wu

      Affiliations

    • Department of Radiology, First Central Hospital of Tianjin Medical University, Tianjin 300171, People's Republic of China
    • ,
  • Ying Liu

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China
    • ,
  • Zhaoyang Fan

      Affiliations

    • Department of Radiology, Northwestern University, Chicago, IL 60611, USA
    • ,
  • Xiangzhi Zhou

      Affiliations

    • Department of Radiology, Northwestern University, Chicago, IL 60611, USA
    • ,
  • Haitao Zhao

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China
    • ,
  • Debiao Li

      Affiliations

    • Department of Radiology, Northwestern University, Chicago, IL 60611, USA
    • ,
  • Yi Huan

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China
    • Corresponding Author InformationCorresponding author. Tel.: +86 29 84775421; fax: +86 29 84775421.

Received 19 March 2009 ,Revised 16 March 2010 ,Accepted 17 March 2010.

References 

  1. Soliman OI, Kirschbaum SW, van Dalen BM, van der Zwaan HB, Delavary BM, Vletter WB, et al. Accuracy and reproducibility of quantitation of left ventricular function by real-time three-dimensional echocardiography versus cardiac magnetic resonance. Am J Cardiol. 2008;102:778–783
  2. Hudsmith LE, Neubauer S. Detection of myocardial disorders by magnetic resonance spectroscopy. Nat Clin Pract Cardiovasc Med. 2008;5(Suppl 2):S49–S56
  3. Beer M, Buchner S, Sandstede J, Viehrig M, Lipke C, Krug A, et al. (31)P-MR Spectroscopy for the evaluation of energy metabolism in intact residual myocardium after acute myocardial infarction in humans. MAGMA. 2001;13:70–75
  4. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 1990;323:1593–1600
  5. Yabe T, Mitsunami K, Okada M, Morikawa S, Inubushi T, Kinoshita M. Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise. Circulation. 1994;89:1709–1716
  6. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810–1818
  7. Kalil-Filho R, de Albuquerque CP, Weiss RG, Mocelim A, Bellotti G, Cerri G, et al. Normal high energy phosphate ratios in “stunned” human myocardium. J Am Coll Cardiol. 1997;30:1228–1232
  8. Bottomley PA, Wu KC, Gerstenblith G, Schulman SP, Steinberg A, Weiss RG. Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation. 2009;119:1918–1924
  9. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795–801
  10. Bottomley PA, Ouwerkerk R. Optimum flip-angles for exciting NMR with uncertain T1 values. Magn Reson Med. 1994;32:137–141
  11. Steinboeck P, Metzler B, Schocke MF, Lechleitner M, Jaschke W, Pachinger MDO. Detection of a silent myocardial infarction with phosphor-31 two-dimensional chemical shift imaging (31P 2-D CSI). Herz. 2003;28:461–465
  12. Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J. 2006;27:942–948
  13. Beer M, Seyfarth T, Sandstede J, Landschütz W, Lipke C, Köstler H, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol. 2002;40:1267–1274
  14. Conway MA, Bottomley PA, Ouwerkerk R, Radda GK, Rajagopalan B. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation. 1998;97:1716–1723
  15. Beyerbacht HP, Lamb HJ, van Der Laarse A, Vliegen HW, Leujes F, Hazekamp MG, et al. Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function. Radiology. 2001;219:637–643
  16. Beer M, Sandstede J, Landschütz W, Viehrig M, Harre K, Horn M, et al. Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans. Eur Radiol. 2000;10:1323–1328
  17. Jung WI, Dietze GJ. 31P nuclear magnetic resonance spectroscopy: a noninvasive tool to monitor metabolic abnormalities in left ventricular hypertrophy in human. Am J Cardiol. 1999;83:19H–24H
  18. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, et al. The epidemiology of heart failure. Eur Heart J. 1997;18:208–225
  19. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665–1671
  20. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–1158
  21. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793–800
  22. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68:785–795
  23. Beanlands RS, Nahmias C, Gordon E, Coates G, deKemp R, Firnau G, et al. The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: a double-blind, placebo-controlled, positron-emission tomography study. Circulation. 2000;102:2070–2075

PII: S0730-725X(10)00103-7

doi: 10.1016/j.mri.2010.03.040

Magnetic Resonance Imaging
Volume 28, Issue 7 , Pages 936-942 , September 2010

Article Tools

* Image Usage & Resolution